Q1 2026: “We expect revenue to be between $171 million and $173 million, reflecting year over year growth of 39% at the midpoint. We expect non-GAAP income from operations to be between $30 million and $32 million, reflecting year over year growth of 108% and non-GAAP operating margin of 18% at the midpoint,” the company said.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health, Inc. options imply 9.7% move in share price post-earnings
- Hinge Health price target lowered to $59 from $66 at Stifel
- Reaffirming Buy on Hinge Health: Strong Win Rates, Sustained Growth, and Limited Competitive Threats Support $65 Target
- Evercore ISI sees limited impact to Hinge from Sword Health-Kaia Health deal
- Darden upgraded, Trade Desk downgraded: Wall Street’s top analyst calls